Individuals Coming Off Anti-Obesity Injections Put On Pounds Four Times Faster Than People Using Diet and Exercise

Fresh analysis indicates that patients who come off new slimming jabs like Mounjaro or Wegovy tend to recover lost weight far faster than those who halt traditional diet and exercise regimens.

Findings released in a prominent health publication demonstrates that while overweight people often shed substantial amounts of their total mass while on the medication, the mass is regained at an average rate of nearly a kilo each month after stopping.

"Users purchasing such medications need to be informed of the danger of fast weight regain when the medication is stopped," warns expert Dr. Susan Jebb.

This pace of regain means a return to starting mass within about a year and a half.

Weighing Approaches

The analysis, which reviewed dozens of studies involving thousands of participants, contrasted the results of GLP-1 agonists with conventional dieting.

The team point out that individuals who shed pounds through diet and exercise typically experience a more gradual weight regain—around 100 grams monthly—after stopping.

Understanding the Fast Rebound

Nutrition scientists believe the mode of action of the drugs accounts for the heightened rebound.

These medications copy a natural hormone called glucagon-like peptide-1, which moderates hunger.

"Long-term administration of the hormone levels far above than normal may cause the system to produce less of its own natural GLP-1, and could diminish sensitivity to its actions," explained Dr. Adam Collins, a dietetics researcher.

"Stopping of this hormone supplement results in hunger is unsuppressed, making binge eating a significant risk."

An Ongoing Issue?

Health authorities recommend the injections for people with weight-linked medical conditions, accompanied by recommended lifestyle changes.

Professionals argue that, considering the likelihood of weight regain, the treatment might need to be life-long.

This perspective is supported by pharmaceutical companies, who say that the findings "underscore the long-term character of obesity," akin to managing conditions like high blood pressure.

Patient Experiences

People who have stopped the medication report a intense return of cravings.

"It felt as if a switch that goes on and you become ravenous," described one woman.

The struggle is worsened if users have not established lasting dietary or behavioural changes during therapy.

Growing Adoption

Figures indicate that millions of adults in the UK have used weight-loss jabs in the past year, with interest being substantial.

• Adoption is more common among females compared to males.
• The 40s and 50s age group shows the greatest level of interest.
• A large proportion access the drugs through private prescriptions rather than public health services.

Finally, researchers stress that while the jabs are powerful tools for shedding pounds, they are not a standalone cure and lasting health benefits likely depends on integrated lifestyle support.